Project overview
Targeted molecular radiotherapy delivered by radiolabelled anti-CD66 as the only conditioning prior to autologous stem cell transplantation for AL-amyloidosis, a Phase I/IIa trial.
Research project
A Phase I Study of Targeted Radiotherapy alone for Stem Cell Transplant Conditioning in Systemic AL Amyloidosis - 'TRALA'
-
Lead researchers:
-
Status:Not active